UPDATE : Saturday, October 12, 2019
상단여백
NOAC race: Pradaxa prescription numbers fall behind fast followers
The first product to gain indications for a disease often maintains a domin...
by Marian Chu  |  2017-09-14 19:02
라인
Opdivo vs. Keytruda - which will doctors choose?
Two blockbuster immunotherapies Opdivo and Keytruda gained insurance covera...
by Marian Chu  |  2017-09-14 17:54
라인
Chong Kun Dang enters an osteoporosis therapy market
Chong Kun Dang has entered an osteoporosis therapy market with Prolia (comp...
by Lee Hye-seon  |  2017-09-14 17:53
라인
AstraZeneca regains momentum with positive Imfinzi results
Astra Zeneca Korea said Thursday it had some good news from its phase 3 Pac...
by Marian Chu  |  2017-09-14 13:34
라인
Amgen, Chong Kun Dang to sell osteoporosis drug in Korea
Amgen Korea said it signed a joint promotion agreement with Korean pharmace...
by Marian Chu  |  2017-09-13 18:33
라인
Alvogen Korea to sell Vivus’ obesity drug
Alvogen Korea said Wednesday that it gained exclusive marketing rights to s...
by Marian Chu  |  2017-09-13 18:16
라인
ASEAN officials visit JW’s manufacturing plant
Officials involved in good manufacturing practice (GMP) in 10 member nation...
by Song Soo-youn  |  2017-09-13 18:07
라인
Opdivo’s expanded indications ease cancer patients’ worries
Ono Pharma Korea and Bristol-Myers Squibb said Wednesday that their blockbu...
by Marian Chu  |  2017-09-13 16:57
라인
Anticoagulant drugs will add SJS Warning
The approval conditions of nine medicines that include rivaroxaban, such as...
by Lee Hye-seon  |  2017-09-13 15:55
라인
Brokerage analyzes profit-sharing structure of Celltrion group
Local stock analysts’ eyes are now on the profit-sharing structure of the C...
by Nam Doo-hyun  |  2017-09-12 16:55
라인
EU approves Abbvie’s Humira as first biologic to treat CHMP
Abbvie Korea, the Korean offshoot of the global biopharmaceutical company, ...
by Marian Chu  |  2017-09-12 15:45
라인
FIP head calls for revitalizing generic substitution
International Pharmaceutical Federation (FIP) has come forward to emphasize...
by Lee Hye-seon  |  2017-09-12 14:34
라인
Lilly’s diabetes drug ahead of Novo Nordisk’s in Q2 market share
Lilly Korea’s diabetes drug Trulicity grabbed the largest market share in K...
by Marian Chu  |  2017-09-12 13:26
라인
Sillajen stock surges upon clinical trial announcement
The share price of Sillajen, a biopharmaceutical company, has been surging ...
by Lee Han-soo  |  2017-09-12 13:26
라인
Ildong, Olix agree to develop new drugs
Ildong Pharmaceutical and Olix Pharmaceuticals, an RNA interference (RNAi)-...
by Lee Han-soo  |  2017-09-11 17:30
라인
Abbvie lands 1st place on Dow Jones Sustainability Index
Global biopharmaceutical Abbvie said Monday it has ranked number one, for t...
by Marian Chu  |  2017-09-11 14:38
라인
GSK’s HIV drug ranked No. 1 in Q2 sales
GlaxoSmithKline (GSK) said Monday its human immunodeficiency virus (HIV) tr...
by Marian Chu  |  2017-09-11 14:37
라인
FDA orders halt on Opidvo trials
Two months after the U.S. Food and Drug Administration halted Merck & Co’s ...
by Marian Chu  |  2017-09-08 16:39
라인
Vivus, Alvogen sign agreement to market diet treatment in Korea
Alvogen Korea 알보젠코리아, a pharmaceutical company, announced Friday that it ha...
by Lee Han-soo  |  2017-09-08 15:24
라인
Teva-Handok wins approval for anti-asthma injection
The Ministry of Food and Drug Safety (MFDS) approved Teva-Handok’s injectio...
by Marian Chu  |  2017-09-07 14:58
여백
여백
여백
Back to Top